Delivery Order SPE2DB24D8003-SPE2DB25FJVCK
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,659.57, is for the delivery of drospirenone-EE 3-0.02 mg tablets (28 count) and has a performance period through June 20, 2024. Dakota Drug, Inc. is a critical vendor for the DLA's medical supply chain, holding a significant $999,999,999.00 Indefinite Delivery Contract (IDC) under the...
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $6,484.12, is scheduled for completion by August 14, 2025, and represents performance work to be conducted at the contractor's Anoka, Minnesota location. The award utilized no set-aside...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $1,148.52 to Dakota Drug, Inc., a self-certified small disadvantaged business headquartered in Anoka, Minnesota. The delivery order was issued on December 17, 2019, with an ultimate completion date of December 18, 2019, and represents a firm fixed price contract with no set-aside designation. Performance of this delivery order was directed to Minot, North Dakota. Dakota Drug, Inc. operates as a critical...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of pharmaceutical products, medical supplies, and healthcare equipment, with a focus on supporting U.S. Armed Forces medical operations. The contract has a ceiling value of $3,151.10 and an ultimate completion date of May 8, 2025. It is part of the DLA Troop Support Medical's ECAT Generation...
- The Defense Logistics Agency awarded a delivery order valued at $4,388.63 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Gemtesa 75 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, is issued under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $32.1K firm fixed-price delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Losartan-HCTZ 100-12.5 mg tablets in quantities of 90 units. The award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a single delivery order under Dakota Drug's existing Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program. This...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $15,860.63, is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of March 20, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
- The Defense Logistics Agency awarded Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, a delivery order valued at $1,561.25 for 100 tablets of Ambien CR 12.5 mg. This firm fixed-price delivery order, awarded on August 5, 2025, is part of Dakota Drug's larger Indefinite Delivery Contract with DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00 and extending through December 31, 2025. The award carries no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $1,985.04 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, on August 21, 2025. The order covers 90 tablets of Jardiance 25 mg, a diabetes management medication, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a continuation of Dakota Drug's pharmaceutical supply support to the federal government. This...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $8,273.67 contract is for the Prime Vendor Pharmaceutical Branch-Philadelphia program, which provides a broad range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract...
- SPE2DB24D8003Indefinite Delivery Contract
- SPE2DB24D8003-SPE2DB25FJVCKDelivery Order
Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a delivery order on August 27, 2025, for Drospirenone-EE 3-0.02 mg tablets (28-count packages) under a firm fixed-price contract valued at $1,724.18. The Defense Logistics Agency, an arm of the U.S. Department of Defense, issued this unrestricted award with an ultimate completion date of August 28, 2025. This delivery order is issued under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program, which carries a total contract ceiling of $999,999,999.00 and runs through December 31, 2025. The pharmaceutical product being delivered supports military healthcare operations across the Department of Defense. Dakota Drug has established itself as a critical supplier within the federal medical procurement marketplace, providing diverse medications and medical supplies to military healthcare facilities. The company's participation in the ECAT Generation V Program enables efficient delivery of commercial pharmaceutical products to support U.S. Armed Forces medical operations. No set-aside designation was applied to this delivery order, and performance will occur at the contractor's location in Anoka, Minnesota.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/27/25 |